MONTREAL, QUEBEC -- (MARKET WIRE) -- March 26, 2007 -- Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today that it will be hosting a conference call and webcast on Wednesday, March 28th, at 9:00 AM ET, to discuss fiscal year 2006 results.
